{"mainPropery":{"diseaseId":5897,"diseaseName":"Neuronal ceroid lipofuscinosis 3","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5897/neuronal-ceroid-lipofuscinosis-3","synonyms":["Juvenile neuronal ceroid lipofuscinosis","Vogt Spielmeyer disease","Spielmeyer Sjogren disease","CLN3 disease, juvenile "],"synonyms-with-source":[{"name":"Juvenile neuronal ceroid lipofuscinosis"},{"name":"Vogt Spielmeyer disease"},{"name":"Spielmeyer Sjogren disease"},{"name":"CLN3 disease, juvenile ","source":"GeneReviews"}],"identifiers":[{"identifierType":"OMIM","identifierId":"204200"},{"identifierType":"ORPHANET","identifierId":"79264"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases"}],"organizations":[{"resourceID":315,"resourceName":"Batten Disease Support and Research Association","abbreviation":"BDSRA","address1":"2780 Airport Drive, Suite 342","address2":"","address3":"","address4":"","address5":"","city":"Columbus","state":"OH","zip":"43219","country":"United States","phone":"","tty":"","tollFree":"1-800-448-4570","fax":"1-866-648-8718","email":"https://bdsra.org/contact-us/","url":"https://bdsra.org/","freeText":""},{"resourceID":317,"resourceName":"Nathan's Battle Foundation","address1":"459 South State Road 135 South","address2":"","address3":"","address4":"","address5":"","city":"Greenwood","state":"IN","zip":"46142 ","country":"United States","phone":"317-888-7396 ","tty":"","tollFree":"","fax":"317-888-0504 ","email":"pmilto@indy.net","url":"http://www.nathansbattle.com"},{"resourceID":2239,"resourceName":"Beyond Batten Disease Foundation","abbreviation":"","address1":"PO Box 50221","address2":"","address3":"","address4":"","address5":"","city":"Austin","state":"TX","zip":"78763","country":"","phone":"+1-512-275-2600","tty":"","tollFree":"1-877-6BATTEN","fax":"512-637-6333","email":"info@beyondbatten.org","url":"https://beyondbatten.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/204200' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=CLN3%5Btiab%5D%20AND%20Neuronal%20ceroid%20lipofuscinosis%5Btiab%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neuronal ceroid lipofuscinosis 3. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Ceroid+lipofuscinosis+neuronal+3%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Neuronal ceroid lipofuscinosis 3. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/juvenile-batten-disease' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Neuronal ceroid lipofuscinosis 3. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":137,"resourceId":315,"resourceName":"Batten Disease Support and Research Association","descriptionText":"The&nbsp;Batten Disease Support and Research Association has a list of&nbsp;<a href='http://bdsra.org/programs-services/centers-of-excellence/' target='_blank'>Batten Disease Centers of Excellence</a>. These centers have&nbsp;a team of professionals who are knowledgeable about, and have experience treating, all forms of Batten disease.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":869,"resourceId":1575,"resourceName":"RDCRN - Lysosomal Disease Network","descriptionText":"The&nbsp;<a href='http://www.rarediseasesnetwork.org/LDN/' target='_blank'>Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br />","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0751383/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/259/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001613.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/batten/detail_batten.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1178391-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022365' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79264' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1428/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search.php?lng=EN&type_list=clinicalLabs_search_simple_shd&data_id=11290&Disease(s)%20concerned=Juvenile-neuronal-ceroid-lipofuscinosis--Batten-disease-&search=ClinicalLabs_Search_Simple&ChdId=11290&ClinicalLabs_ClinicalLabs_Search_diseaseGroup=batten-disease&ClinicalLabs_ClinicalLabs_Search_diseaseType=Pat&ClinicalLabs_ClinicalLabs_Search_country=NN&ClinicalLabs_ClinicalLabs_Search_GeographicType=null&ClinicalLabs_ClinicalLabs_Search_ClinicalLabsList_Sort=QoS' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Neuronal ceroid lipofuscinosis 3. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Neuronal ceroid lipofuscinosis 3:<br />\r\n<a href='https://www.urmc.rochester.edu/neurology/batten-disease-center/research/research-clinical-trials.aspx' target='_blank'>Batten Disease Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":1514,"questionText":"What is neuronal ceroid lipofuscinosis 3?","answerText":"<strong>Neuronal ceroid lipofuscinosis 3 (CLN3-NCL)</strong> is a rare condition that affects the nervous system. Signs and symptoms generally develop between age 4 and 8 years, although later onset cases have been reported. Affected people may experience rapidly progressive vision loss, developmental regression (loss of acquired milestones), cognitive decline, heart problems, seizures, speech disturbances, behavioral problems (including aggression), and movement abnormalities. Life expectancy generally ranges from the late teens to the 30's. CLN3-NCL is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/locuslink=1201\" target=\"_blank\">CLN3</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner. Treatment options are limited to therapies that can help relieve some of the symptoms.[9561][9562]","dateModified":"2015-09-01T00:00:00"},"basicQuestions":[{"questionId":6435,"questionText":"What causes neuronal ceroid lipofuscinosis 3?","answerText":"Neuronal ceroid lipofuscinosis 3 (CLN3-NCL) is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/CLN3\" target=\"_blank\">CLN3</a></em> gene. This gene provides instructions for making a protein whose function is unknown. However, it appears to be important for the normal function of cell structures call lysosomes.[5512]<br />\r\n<br />\r\nAlthough researchers do not completely understand how mutations in the <em>CLN3</em> gene lead to the signs and symptoms of CLN3-NCL, they appear to disrupt the function of lysosomes (structures in the cell that normally digest and recycle different substances). When the lysosomes don't work properly, lipopigments (materials made of fats and proteins) build up in cells of the brain and the eye as well as in skin, muscle, and many other tissues. Researchers believe that this build up plays a key role in the development of the many features of CLN3-NCL.[5512]","dateModified":"2015-09-01T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":5512,"authors":"","articleTitle":"Juvenile Batten disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/juvenile-batten-disease","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":10739,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":36549,"abbreviatedInquiry":"Are there any exogenous (outside) factors that cause or worsen Batten disease?","caseQuestions":[{"questionId":6435,"questionText":"What causes neuronal ceroid lipofuscinosis 3?","answerText":"Neuronal ceroid lipofuscinosis 3 (CLN3-NCL) is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/CLN3\" target=\"_blank\">CLN3</a></em> gene. This gene provides instructions for making a protein whose function is unknown. However, it appears to be important for the normal function of cell structures call lysosomes.[5512]<br />\r\n<br />\r\nAlthough researchers do not completely understand how mutations in the <em>CLN3</em> gene lead to the signs and symptoms of CLN3-NCL, they appear to disrupt the function of lysosomes (structures in the cell that normally digest and recycle different substances). When the lysosomes don't work properly, lipopigments (materials made of fats and proteins) build up in cells of the brain and the eye as well as in skin, muscle, and many other tissues. Researchers believe that this build up plays a key role in the development of the many features of CLN3-NCL.[5512]","dateModified":"2015-09-01T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":5512,"authors":"","articleTitle":"Juvenile Batten disease","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/juvenile-batten-disease","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6436,"questionText":"Are there any exogenous (outside) factors that cause or worsen neuronal ceroid lipofuscinosis 3?","answerText":"<a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682237.html\" target=\"_blank\">Carbamazepine</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682022.html\" target=\"_blank\">phenytoin</a> may increase seizure activity and <a href=\"http://www.mayoclinic.org/diseases-conditions/myoclonus/basics/definition/con-20027364\" target=\"_blank\">myoclonus</a> (involuntary muscle jerks) in people with neuronal ceroid lipofuscinosis 3 (CLN3-NCL) and other types of neuronal ceroid lipofuscinoses (NCLs). In some cases, these medications have been associated with worsening of symptoms.[9561] <br />\r\n<br />\r\nIn one study of people with CLN3-NCL, <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682412.html\" target=\"_blank\">valproic acid</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682279.html\" target=\"_blank\">clonazepam</a> were noted to have severe side effects. More specifically, 50 percent of people receiving valproic acid had sleep disturbances or excessive sedation. Clonazepam seemed to stimulate salivation and respiratory secretions, increasing the risk of pneumonia.[9561]","dateModified":"2015-09-01T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":9561,"authors":"Mole SE, Williams RE","articleTitle":"Neuronal Ceroid-Lipofuscinoses","bookWebsiteJournalTitle":"GeneReviews","date":"August 1, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1428/","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5621,"phenoTypeName":"Abnormal electroretinogram","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8521,"phenoTypeName":"Abnormal pyramidal sign","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13705,"phenoTypeName":"Abnormality of extrapyramidal motor function","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10117,"phenoTypeName":"Abnormality of visual evoked potentials","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6005,"phenoTypeName":"Behavioral abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13458,"phenoTypeName":"Bilateral tonic-clonic seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10089,"phenoTypeName":"Blindness","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13680,"phenoTypeName":"Focal-onset seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10579,"phenoTypeName":"Iris hypopigmentation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11418,"phenoTypeName":"Motor deterioration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13842,"phenoTypeName":"Neurological speech impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10492,"phenoTypeName":"Retinopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9413,"phenoTypeName":"Abnormal cerebellum morphology","percentRanges":"-"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","percentRanges":"-"},{"phenoTypeId":13447,"phenoTypeName":"Cerebral atrophy","percentRanges":"-"},{"phenoTypeId":13483,"phenoTypeName":"Concentric hypertrophic cardiomyopathy","percentRanges":"-"},{"phenoTypeId":14508,"phenoTypeName":"Curvilinear intracellular accumulation of autofluorescent lipopigment storage material","percentRanges":"-"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","percentRanges":"-"},{"phenoTypeId":14504,"phenoTypeName":"Fingerprint intracellular accumulation of autofluorescent lipopigment storage material","percentRanges":"-"},{"phenoTypeId":5610,"phenoTypeName":"Glaucoma","percentRanges":"-"},{"phenoTypeId":13584,"phenoTypeName":"Increased extraneuronal autofluorescent lipopigment","percentRanges":"-"},{"phenoTypeId":13707,"phenoTypeName":"Increased neuronal autofluorescent lipopigment","percentRanges":"-"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","percentRanges":"-"},{"phenoTypeId":9194,"phenoTypeName":"Macular degeneration","percentRanges":"-"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","percentRanges":"-"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","percentRanges":"-"},{"phenoTypeId":9388,"phenoTypeName":"Parkinsonism","percentRanges":"-"},{"phenoTypeId":8080,"phenoTypeName":"Progressive inability to walk","percentRanges":"-"},{"phenoTypeId":5641,"phenoTypeName":"Progressive visual loss","percentRanges":"-"},{"phenoTypeId":11440,"phenoTypeName":"Psychomotor deterioration","percentRanges":"-"},{"phenoTypeId":6006,"phenoTypeName":"Psychosis","percentRanges":"-"},{"phenoTypeId":5620,"phenoTypeName":"Rod-cone dystrophy","percentRanges":"-"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","percentRanges":"-"},{"phenoTypeId":5656,"phenoTypeName":"Undetectable electroretinogram","percentRanges":"-"},{"phenoTypeId":15556,"phenoTypeName":"Vacuolated lymphocytes","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Neuronal_ceroid_lipofuscinosis_3"}